Article History
Received: 27 August 2019
Accepted: 7 December 2019
First Online: 24 February 2020
Competing interests
: Dario Neri is a cofounder and shareholder of Philogen SpA (Siena, Italy), the company that owns the F8 and the L19 antibodies. No potential conflicts of interest were disclosed by the other authors.